187 related articles for article (PubMed ID: 36967100)
1. Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis.
Hiremath G; Sun L; Collins MH; Bonis PA; Arva NC; Capocelli KE; Chehade M; Davis CM; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Khoury P; Mukkada VA; Martin LJ; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME; Koyama T; Dellon ES
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2807-2816.e3. PubMed ID: 36967100
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the Eosinophilic Esophagitis Histologic Scoring System in Distinguishing Active Eosinophilic Esophagitis From Remission and Gastroesophageal Reflux Disease.
Lin B; Rabinowitz S; Haseeb MA; Gupta R
Gastroenterology Res; 2021 Aug; 14(4):220-226. PubMed ID: 34527091
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic Esophagitis Histologic Scoring System: Correlation with Histologic, Endoscopic, and Symptomatic Disease and Clinical Use.
Alexander RG; Ravi K; Collins MH; Lavey CJ; Snyder DL; Lennon RJ; Kassmeyer BA; Katzka DA; Alexander JA
Dig Dis Sci; 2023 Sep; 68(9):3573-3583. PubMed ID: 37432533
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Adequate Lamina Propria Sampling and Presence of Lamina Propria Fibrosis in Children with Eosinophilic Esophagitis.
Hiremath G; Choksi YA; Acra S; Correa H; Dellon ES
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1814-1823.e1. PubMed ID: 32707338
[TBL] [Abstract][Full Text] [Related]
5. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring.
Collins MH; Martin LJ; Alexander ES; Boyd JT; Sheridan R; He H; Pentiuk S; Putnam PE; Abonia JP; Mukkada VA; Franciosi JP; Rothenberg ME
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 26857345
[TBL] [Abstract][Full Text] [Related]
6. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
7. Intra- and interobserver agreement of histopathological findings in pediatric patients with eosinophilic esophagitis.
Vieira MC; Gugelmin ES; Percicote AP; Ribeiro MG; de Miranda RA; Vieira GG; Ribeiro LBM; Truppel SK; Filho NAR
J Pediatr (Rio J); 2022; 98(1):26-32. PubMed ID: 33964213
[TBL] [Abstract][Full Text] [Related]
8. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
[TBL] [Abstract][Full Text] [Related]
9. Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis.
Wang J; Park JY; Huang R; Souza RF; Spechler SJ; Cheng E
Gastrointest Endosc; 2018 May; 87(5):1207-1214.e3. PubMed ID: 29309779
[TBL] [Abstract][Full Text] [Related]
10. Application of the Eosinophilic Esophagitis Histology Scoring System Grade Scores in Patients at British Columbia Children's Hospital.
Cruz J; Irvine MA; Avinashi V; Chan ES; Vallance BA; Soller L; Bush JW
Fetal Pediatr Pathol; 2022 Dec; 41(6):962-976. PubMed ID: 35094661
[TBL] [Abstract][Full Text] [Related]
11. Correlation of endoscopic signs and mucosal alterations in children with eosinophilic esophagitis.
Hiremath G; Correa H; Acra S; Dellon ES
Gastrointest Endosc; 2020 Apr; 91(4):785-794.e1. PubMed ID: 31785273
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis.
Katzka DA; Ravi K; Geno DM; Smyrk TC; Iyer PG; Alexander JA; Mabary JE; Camilleri M; Vaezi MF
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1242-1248.e1. PubMed ID: 25592662
[TBL] [Abstract][Full Text] [Related]
13. Pathology of eosinophilic esophagitis: what the clinician needs to know.
Odze RD
Am J Gastroenterol; 2009 Feb; 104(2):485-90. PubMed ID: 19174804
[TBL] [Abstract][Full Text] [Related]
14. Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.
Zhang S; Caldwell JM; Rochman M; Collins MH; Rothenberg ME
J Allergy Clin Immunol; 2024 May; 153(5):1381-1391.e6. PubMed ID: 38395083
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.
Schoepfer AM; Simko A; Bussmann C; Safroneeva E; Zwahlen M; Greuter T; Biedermann L; Vavricka S; Godat S; Reinhard A; Saner C; Maye H; Sempoux C; Brunel C; Blanchard C; Simon D; Simon HU; Straumann A
Am J Gastroenterol; 2018 Mar; 113(3):348-357. PubMed ID: 29336433
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis.
Hiremath G; Sun L; Correa H; Acra S; Collins MH; Bonis P; Arva NC; Capocelli KE; Falk GW; King E; Gonsalves N; Gupta SK; Hirano I; Mukkada VA; Martin LJ; Putnam PE; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME; Koyama T; Dellon ES
Am J Gastroenterol; 2022 Feb; 117(2):272-279. PubMed ID: 34932022
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Fibroblast Crosstalk in Eosinophilic Esophagitis.
Muir AB; Karakasheva TA; Whelan KA
Cell Mol Gastroenterol Hepatol; 2024; 17(5):713-718. PubMed ID: 38316214
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.
Abu-Sultaneh SM; Durst P; Maynard V; Elitsur Y
Dig Dis Sci; 2011 Jan; 56(1):97-102. PubMed ID: 20458625
[TBL] [Abstract][Full Text] [Related]
19. Development and dysfunction of structural cells in eosinophilic esophagitis.
Laky K; Frischmeyer-Guerrerio PA
J Allergy Clin Immunol; 2024 Jun; 153(6):1485-1499. PubMed ID: 38849184
[TBL] [Abstract][Full Text] [Related]
20. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
